[
    [
        {
            "time": "2023-03-15",
            "original_text": "Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Eli Lilly",
                    "arthritis",
                    "tanezumab",
                    "FDA",
                    "snag"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-20",
            "original_text": "U.S. stops distribution of Lilly's COVID-19 therapy due to impact of variants",
            "features": {
                "keywords": [
                    "U.S.",
                    "Lilly",
                    "COVID-19",
                    "therapy",
                    "variants"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "U.S. stops distribution of Lilly's COVID-19 therapy due to impact of variants",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-05-10",
            "original_text": "Global Life Sciences CDMO Selects Kneat's e-Validation SaaS Platform",
            "features": {
                "keywords": [
                    "Global",
                    "Life Sciences",
                    "CDMO",
                    "Kneat",
                    "e-Validation",
                    "SaaS"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Global Life Sciences CDMO Selects Kneat's e-Validation SaaS Platform",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]